The use of HCV immunogenic peptide or a derivative thereof in the prevention or treatment of arthritis
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
N/A
app pub date -
Mar 28, 2014
filing date -
Sep 30, 2011
priority date (Note) -
Abandoned
status (Latency Note)
Importance
|
US Family Size
|
Non-US Coverage
|
Abstract
The present invention provides the use of hepatitis C virus immunogenic peptides or derivative thereof in the manufacture of a pharmaceutical for preventing or treating arthritis, wherein the peptide or derivative thereof is a peptide represented by formula I or pharmaceutically acceptable salt or ester thereof. The present invention further provides a method for treating arthritis, including administering a pharmaceutical containing therapeutically effective amount of said peptide or derivative thereof to a patient. Xaa1-Gln-Xaa2-Xaa3-Thr-Ser-Gly-Xaa4 (formula I), wherein, Xaa1 is deleted, or Xaa1 is Ala, Gly, Val, Leu or Ile, Xaa2 is Thr or Ser, Xaa3 is Tyr, Phe or Trp, and Xaa4 is deleted, or Xaa4 is Ala, Gly, Val, Leu, Ile or Pro.
First Claim
Other Claims data not available
Family
| Country | kind | publication No. | Filing Date |
|---|---|---|---|
| WO | A1 | WO2013044500 | Sep 30, 2011 |
| CN | A | CN104780930 | Sep 30, 2011 |
International Classification(s)
- 2014 Application Filing Year
- C07K Class
- 4412 Applications Filed
- 3459 Patents Issued To-Date
- 78.40 % Issued To-Date
Cited Art Landscape
Patent Citation Ranking
- 0 Citation Count
- C07K Class
- 0 % this patent is cited more than
- 11 Age